October 2024's Top KRX Growth Stocks With High Insider Ownership

The South Korean market has shown positive momentum, rising 1.3% over the last week and 4.1% over the past year, with earnings anticipated to grow significantly in the coming years. In this environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those within the company and potential alignment of interests with shareholders.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.4%	35.6%
Seojin SystemLtd (KOSDAQ:A178320)	30.8%	49.1%
Bioneer (KOSDAQ:A064550)	15.8%	97.6%
Oscotec (KOSDAQ:A039200)	26.1%	122%
ALTEOGEN (KOSDAQ:A196170)	26.6%	99.5%
Vuno (KOSDAQ:A338220)	19.5%	110.9%
HANA Micron (KOSDAQ:A067310)	18.3%	100.3%
Park Systems (KOSDAQ:A140860)	33%	34.6%
UTI (KOSDAQ:A179900)	33.1%	134.6%
Techwing (KOSDAQ:A089030)	18.7%	83.6%

Click here to see the full list of 85 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩19.60 trillion.

Operations: The company's revenue is primarily derived from its biotechnology segment, totaling ₩90.79 billion.

Insider Ownership: 26.6%

Earnings Growth Forecast: 99.5% p.a.

ALTEOGEN is positioned for significant growth, with revenue expected to grow at 64.2% annually, outpacing the South Korean market's 10.5%. The company's return on equity is forecasted to be very high in three years. Despite past shareholder dilution, ALTEOGEN trades at a substantial discount to its estimated fair value and is expected to become profitable within three years, surpassing average market growth rates. No recent insider trading activity has been reported.

• Get an in-depth perspective on ALTEOGEN's performance by reading our analyst estimates report here.
• Insights from our recent valuation report point to the potential overvaluation of ALTEOGEN shares in the market.

Enchem (KOSDAQ:A348370)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Enchem Co., Ltd. manufactures and sells electrolytes and additives for secondary batteries and EDLC, with a market cap of ₩4.42 billion.

Operations: The company's revenue segment focuses on electronic components and parts, generating ₩348.75 million.

Insider Ownership: 19.4%

Earnings Growth Forecast: 155.2% p.a.

Enchem is poised for substantial growth, with revenue projected to increase by 63% annually, significantly outpacing the South Korean market's 10.5%. The company is expected to achieve profitability within three years, surpassing average market growth rates. However, shareholders have experienced dilution in the past year. Despite high volatility in its share price over recent months, there is no recent insider trading activity reported.

• Unlock comprehensive insights into our analysis of Enchem stock in this growth report.
• Our expertly prepared valuation report Enchem implies its share price may be too high.

HYBE (KOSE:A352820)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management, with a market cap of ₩7.44 trillion.

Operations: The company's revenue is primarily derived from Label (₩1.28 trillion), Platform (₩361.12 million), and Solution (₩1.24 trillion) segments.

Insider Ownership: 32.5%

Earnings Growth Forecast: 42.2% p.a.

HYBE's revenue is forecast to grow at 14% annually, outpacing the broader South Korean market. Despite recent earnings challenges, with net income declining significantly year-over-year, analysts remain optimistic about a potential 43.6% stock price increase. The company recently completed a share buyback program for KRW 26.09 billion to stabilize its stock price. While trading below estimated fair value, HYBE's return on equity is expected to be modest in three years.

• Click to explore a detailed breakdown of our findings in HYBE's earnings growth report.
• Our valuation report unveils the possibility HYBE's shares may be trading at a discount.

Where To Now?

• Gain an insight into the universe of 85 Fast Growing KRX Companies With High Insider Ownership by clicking here.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com